Retatrutide Shows Promise in Type 2 Diabetes Glycemic Control Study | Retatrutide News

The TRANSCEND-T2D-1 trial on retatrutide for Type 2 Diabetes has been completed, assessing its efficacy and safety. This study is crucial for understand...
Clinical Trials · October 28, 2026